Accelerating drug discovery through genomics and AI

29 Jan 2026
AI In Drug Discovery Stage

The outcomes: 

  • Better understanding of patient journeys to enable discovery of translational opportunities 

  • Integration of genetic, electronic health records (EHR), and molecular data to enable discovery through biological mechanisms across disease areas 

Speakers
Zhihao Ding
Zhihao Ding, Director and Global Head of Human Genetics; Head of Animal Health Genomics, - Boehringer Ingelheim